Fidelity Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-305,225
Closed -$31.1M 5613
2023
Q2
$31.1M Buy
305,225
+180,740
+145% +$18.4M ﹤0.01% 1457
2023
Q1
$11.3M Sell
124,485
-259,591
-68% -$23.6M ﹤0.01% 1826
2022
Q4
$14.6M Sell
384,076
-131,805
-26% -$5.01M ﹤0.01% 1746
2022
Q3
$13M Sell
515,881
-13,669
-3% -$344K ﹤0.01% 1787
2022
Q2
$16.1M Buy
529,550
+114,889
+28% +$3.49M ﹤0.01% 1740
2022
Q1
$13.6M Buy
414,661
+184,021
+80% +$6.03M ﹤0.01% 1988
2021
Q4
$6.08M Sell
230,640
-587,025
-72% -$15.5M ﹤0.01% 2300
2021
Q3
$82.3M Buy
817,665
+67,732
+9% +$6.81M 0.01% 1189
2021
Q2
$106M Buy
749,933
+689,001
+1,131% +$97.5M 0.01% 1099
2021
Q1
$6.08M Sell
60,932
-424,100
-87% -$42.3M ﹤0.01% 2204
2020
Q4
$60M Sell
485,032
-7,384
-1% -$913K 0.01% 1253
2020
Q3
$48M Sell
492,416
-374,432
-43% -$36.5M ﹤0.01% 1211
2020
Q2
$135M Buy
866,848
+140,478
+19% +$21.9M 0.01% 750
2020
Q1
$105M Buy
726,370
+367,402
+102% +$53M 0.01% 740
2019
Q4
$73.4M Buy
358,968
+248,565
+225% +$50.8M 0.01% 1040
2019
Q3
$8.86M Buy
110,403
+61,606
+126% +$4.95M ﹤0.01% 1878
2019
Q2
$4.6M Sell
48,797
-112,900
-70% -$10.7M ﹤0.01% 2116
2019
Q1
$13.8M Sell
161,697
-145,900
-47% -$12.5M ﹤0.01% 1741
2018
Q4
$17.3M Sell
307,597
-69,000
-18% -$3.87M ﹤0.01% 1615
2018
Q3
$30.8M Sell
376,597
-92,393
-20% -$7.55M ﹤0.01% 1503
2018
Q2
$16.4M Sell
468,990
-160,861
-26% -$5.63M ﹤0.01% 1795
2018
Q1
$12.9M Sell
629,851
-29,440
-4% -$604K ﹤0.01% 1883
2017
Q4
$18.7M Sell
659,291
-13,600
-2% -$385K ﹤0.01% 1747
2017
Q3
$20.9M Buy
672,891
+258,400
+62% +$8.04M ﹤0.01% 1680
2017
Q2
$13.1M Buy
414,491
+176,885
+74% +$5.6M ﹤0.01% 1843
2017
Q1
$5.38M Buy
237,606
+68,600
+41% +$1.55M ﹤0.01% 2155
2016
Q4
$3.69M Sell
169,006
-310,018
-65% -$6.77M ﹤0.01% 2255
2016
Q3
$12.6M Sell
479,024
-70,976
-13% -$1.87M ﹤0.01% 1891
2016
Q2
$10.9M Buy
+550,000
New +$10.9M ﹤0.01% 1926